Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - A low endemic country

Journal of Viral Hepatitis

Volumn 15, Issue 7, 2008, Pages 531-537

  Strauss, Reinhild ^a,f   Törner, Anna ^b,c   Duberg, Ann Sofi ^d   Hultcrantz, Rolf ^e   Ekdahl, Karl ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c Stockholm Group for Epidemic Modelling   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f Federal Ministry for Health   (Austria)

Author keywords

Cancer registry; Cohort study; Epidemiology; Hepatitis C virus infection; Hepatocellular carcinoma; Relative risk

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SWEDEN; VIRUS TRANSMISSION;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; SUBSTANCE ABUSE, INTRAVENOUS; SWEDEN;

EID: 44849128679     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.00979.x     Document Type: Article

References (40)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 1989 244 : 359 362.
2. Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology 2000 31 : 1014 1018.
3. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 1999 340 : 1228 1233.
4. Soucie JM, Richardson LC, Evatt BL et al. Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males. Transfusion 2001 41 : 338 343.
5. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-aquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 2000 32 : 582 587.
6. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpoder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusional hepatitis. Hepatology 1991 14 : 969 974.
7. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997 349 : 825 832.
8. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995 332 : 1463 1466.
9. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997 26 (Suppl. 1 34 38.
10. Lunel F, Musset L. Hepatitis C virus infection and cryoglobulinemia. J Hepatol 1998 29 : 848 855.
11. De Rosa G, Gobbo ML, De Renzo A et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997 55 : 77 82.
12. Mizorogi F, Hiramoto J, Nozato A et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Int Med 2000 39 : 112 117.
13. Mattsson L, Weiland O, Glaumann H. Long-term follow-up of chronic post-transfusional non-A, non-B hepatitis: clinical and histological outcome. Liver 1988 8 : 184 188.
14. Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S. Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10 - year period. J Int Med 1992 232 : 33 42.
15. Verbaan H, Hoffmann G, Lindgren S, Nilsson S, Widell A, Eriksson S. Long-term outcome of chronic hepatitis C infection in a low-prevalence area. Scand J Gastroenterol 1998 33 : 650 655.
16. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors-the role of parenteral and sexual transmission. Scand J Infect Dis 1995 27 : 99 104.
17. Hoffmann G, Berglund G, Elmståhl S et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000 35 : 861 865.
18. Duberg AS, Nordström M, Törner A et al. Non-Hodgkin's Lymphoma and other nonhepatic malignancies in Swedish Patients with hepatitis C virus infection. Hepatology 2005 41 : 652 659.
19. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number system of Sweden, Norway, Denmark, and Israel. Vital Health Stat 1980 2 : 1 59.
20. Jansson A, Arneborn M, Ekdahl K. Sensitivity of the Swedish statutory reporting system for communicable diseases 1998-2002, assessed by the capture-recapture method. Epidemiol Inf 2005 133 : 401 407.
21. Mattsson B Cancer Registration in Sweden: Studies on Completeness and Validity of Incidence and Mortality Registers. PhD Dissertation. Stockholm, Sweden : Karolinska Institutet, 1984.
22. Weiland O, Berg JV, Bjorvatn B, Flehmig B, Lundbergh P. Acute viral hepatitis A, B and non-A, non-B in Stockholm in the 1950s and 1970s: a comparison. Infection 1981 9 : 268 274.
23. Bläckberg J, Braconier JH, Widell A, Kidd-Ljunggren K. Long-term outcome of acute hepatitis B and C in an outbreak of hepatitis in 1969-72. Eur J Clin Microbiol Infect Dis 2000 19 : 21 26.
24. Månsson AS, Moestrup T, Nordenfelt E, Widell A. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000 32 : 253 258.
25. Widell A, Hansson BG, Berntorp E et al. Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B. Scand J Infect Dis 1991 23 : 19 24.
26. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996 86 : 655 661.
27. Khan MH, Farrell GC, Byth K et al. Which patients with hepatitis C develop liver complications? Hepatology 2000 31 : 513 520.
28. Seeff LB. Why is there such difficulty in defining the natural history of hepatitis? Transfusion 2000 40 : 1161 1164.
29. Freeman AJ, Dore GJ, Law MG et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001 34 : 809 816.
30. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002 36 : 35 46.
31. Amin J, Dore GJ, O'Connell DL et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatology 2006 45 : 197 203.
32. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000 284 : 450 456.
33. Deuffic S, Buffat L, Poynard T, Vallera AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999 29 : 1796 1601.
34. Bissell DM. Sex and hepatic fibrosis. Hepatology 1999 29 : 988 989.
35. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003 139 : 817 823.
36. Stokkeland K, Brandt L, Ekbom A, Osby U, Hultcrantz R. Morbidity and mortality in liver diseases in Sweden 1969-2001 in relation to alcohol consumption. Scand J Gastroenterol 2006 41 : 459 464.
37. Peters MG, Terrault N. Alcohol use and hepatitis C. Hepatology 2002 36 (Suppl. 1 220 225.
38. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002 36 (Suppl. 1 201 209.
39. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C coinfected patients. The multivirc Group. Hepatology 1999 30 : 1054 1058.
40. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997 25 : 211 215.